Personalis, Inc. (PSNL)
16.05
-0.35
(-2.13%)
USD |
NASDAQ |
Oct 06, 16:00
16.05
0.00 (0.00%)
After-Hours: 19:49
Personalis Cash from Investing (Quarterly) : 38.16M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.16M |
| March 31, 2026 | -46.01M |
| December 31, 2025 | -14.38M |
| September 30, 2025 | 18.72M |
| June 30, 2025 | -4.371M |
| March 31, 2025 | -22.54M |
| December 31, 2024 | -26.18M |
| September 30, 2024 | -28.18M |
| June 30, 2024 | 12.99M |
| March 31, 2024 | 6.301M |
| December 31, 2023 | -11.64M |
| September 30, 2023 | -8.605M |
| June 30, 2023 | 19.55M |
| March 31, 2023 | 13.79M |
| December 31, 2022 | 21.85M |
| September 30, 2022 | 10.83M |
| June 30, 2022 | 23.02M |
| Date | Value |
|---|---|
| March 31, 2022 | -3.161M |
| December 31, 2021 | 39.91M |
| September 30, 2021 | 29.67M |
| June 30, 2021 | -47.10M |
| March 31, 2021 | -82.54M |
| December 31, 2020 | -63.14M |
| September 30, 2020 | 5.647M |
| June 30, 2020 | -7.615M |
| March 31, 2020 | -0.035M |
| December 31, 2019 | -34.85M |
| September 30, 2019 | -43.93M |
| June 30, 2019 | -1.841M |
| March 31, 2019 | -0.96M |
| December 31, 2018 | -0.671M |
| September 30, 2018 | -1.944M |
| June 30, 2018 | -3.928M |
| March 31, 2018 | -1.309M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tempus AI, Inc. | -11.09M |
| 10X Genomics, Inc. | -7.735M |
| Alamar Biosciences, Inc. (California) | -120.80M |
| Adaptive Biotechnologies Corp. | -43.48M |
| Champions Oncology, Inc. | -0.055M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -25.77M |
| Cash from Financing (Quarterly) | 7.988M |
| Free Cash Flow | -100.98M |
| Free Cash Flow Per Share (Quarterly) | -0.2803 |
| Free Cash Flow to Equity (Quarterly) | -28.77M |
| Free Cash Flow to Firm (Quarterly) | -29.52M |
| Free Cash Flow Yield | -6.44% |